Lymphoma Program

Recent News

Dr. Sweetenham Given UCan Leadership Recognition

Congratulations to Dr. John Sweetenham for recently receiving a recognition award from the Utah Cancer Action Network (UCAN) for his service as UCAN Chair, 2015-2016.  UCAN is Utah’s comprehensive cancer control coalition, comprised of a diverse, professional group of stakeholders from across the state who represent a variety of groups and interest areas, including state and local governments, private and nonprofit organizations, academic institutions, researchers, physicians, cancer survivors, caregivers, patients, and advocates.  UCAN’s goals are to:

  • Develop, implement, and evaluate a comprehensive plan to reduce cancer morbidity and mortality in Utah
  • Work collectively to ensure continued progress with comprehensive cancer issues across Utah
  • Provide many opportunities for collaboration among coalition partners through activities designed to address the many facets of cancer prevention and control

July 2016

Deborah Stephens

Dr. Stephens to Speak in Salt Lake City for Patients with Chronic Lymphocytic Leukemia

Dr. Stephens was selected to speak at an “Ask the Doctor” Session for the Lymphoma Research Foundation.  The “Ask the Doctor” Program is a national series of two-hour, topic-specific community based-programs that provide an update on lymphoma treatment by a medical doctor with an extensive question and answer session.  Dr. Stephens will speak on June 16, 2016 at the Downtown Courtyard by Marriott from 6-8:30pm.  For more information on registration visit the Lymphoma website.

June 2016

Halwani Ahmed

Dr. Halwani Selected as a Research Scholar

Dr. Ahmad Halwani has been selected as a University of Utah Vice President's Clinical and Translational (VPCAT) Research Scholar for the 2016-2017 year. This award supports junior faculty at University of Utah Health who are committed to research careers. This is a competitive mentored program to provide leadership competencies and develop the essential research knowledge and practical skills to be an effective clinical or translational researcher. We congratulate Dr. Halwani on his selection as a VPCAT Scholar.

January 2016